Elisabetta Chiesa

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

Antonella d’Arminio Monforte, Letizia Testa, Fulvio Adorni et al. · AIDS · 1998 · 142 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

CD4 cell counts at the third month of HAART may predict clinical failure

Antonella d‚Arminio Monforte, Valeria Testori, Fulvio Adorni et al. · AIDS · 1999 · 52 citations

Life Sciences, Immunology, Infectious Diseases +14

Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy

Teresa Bini, Letizia Testa, Elisabetta Chiesa et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2000 · 34 citations

Public Health, Pharmacology, Pharmacotherapy +17

Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals

Marco Bongiovanni, Paola Cicconi, Simona Landonio et al. · International Journal of Antimicrobial Agents · 2005 · 33 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Virological Success of Lopinavir/Ritonavir Salvage Regimen is Affected by an Increasing Number of Lopinavir/Ritonavir-Related Mutations

Marco Bongiovanni, Teresa Bini, Fulvio Adorni et al. · Antiviral Therapy · 2003 · 25 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17